Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Dosing inaccuracies the active ingredient may be stronger or weaker than intended
Unlike semaglutide which only targets GLP-1 receptors, tirzepatides additional GIP receptor activity is thought to enhance insulin secretion, improve insulin sensitivity, and produce greater reductions in appetite and body weight
Our Score: 9.3 / 10
For those already exercising, continue your current routine but avoid making dramatic increases in intensity right as you start therapy
Email id is needed for Inquiry
The study was funded by semaglutide maker Novo Nordisk
US$ 29.04
US$ 28.24
US$ 24.52
US$ 24.82
